Description
Thrombin receptor agonist is a peptide that activates thrombin-mediated platelet aggregation signaling pathways; it mimics the effects of thrombin, activating protease-activated receptor-1 (PAR1) in wounds in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
Thrombin receptor agonist is a peptide that activates thrombin-mediated platelet aggregation signaling pathways; it mimics the effects of thrombin, activating protease-activated receptor-1 (PAR1) in wounds in vivo.
Cas No. | 137339-65-2 |
---|---|
Purity | ≥95% |
Formula | C81H118N20O23 |
Formula Wt. | 1739.96 |
Synonym | TRAP-14, TRAP |
Solubility | Soluble in water (0.9 mg/mL). |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Windeløv NA, Sørensen AM, Perner A, et al. Platelet aggregation following trauma: a prospective study. Blood Coagul Fibrinolysis. 2014 Jan;25(1):67-73. PMID: 23945060.
Kreutz RP, Breall JA, Kreutz Y, et al. Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response. Thromb Res. 2012 Aug;130(2):198-202. PMID: 22459907.
Polycationic aminoglycoside; protein translatio...
Imidazole; 14-α demethylase inhibitor, potenti...
NLRP3 and caspase-1 inhibitor.
Endogenous peptide hormone; motilin agonist.
IMPDH inhibitor.
Docetaxel impurity
Flavonoid glycoside found in Pyrola.
Neuromodulator, biomarker
Tyrosine kinase inhibitor.
PKA substrate.
FGFR inhibitor.
BACE1 inhibitor
Diterpene lactone found in Ginkgo; GABA-A, α-1...
p110α PI3K inhibitor.
GSK-3 and CDK inhibitor.
Dihydrofolate reductase inhibitor.
D2/3 antagonist, hERG K+ channel blocker.
O-methylated coumarin; Ca2+ channel blocker.
Endogenous peptide, produced by activation of P...
AT1 antagonist.